Search
for

    Sort by

    Research 91–120 of 132

    1. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19 Microorganisms · 2022 · 8 citations
    2. The interaction between finasteride and corticosterone levels: implications for depression-, and anxiety-like behavior and hippocampal synaptic plasticity in male rats Psychopharmacology · 2025
    3. Role of Drug Repurposing in Sustainable Drug Discovery IntechOpen eBooks · 2023
    4. Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? Endocrine · 2018 · 40 citations
    5. Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI) Zenodo (CERN European Organization for Nuclear Research) · 2023
    6. Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride Journal of The American Academy of Dermatology · 2016
    7. Trichotillomania in long COVID successfully treated with escitalopram: A case report Psychiatry and Clinical Neurosciences Reports · 2025
    8. Citalopram–induced delusions in an older adult European Psychiatry · 2017
    9. Post-Exposure Syndromes as State-Space Trapping: A set-theoretic perspective on PSSD and the post-exposure family. Zenodo (CERN European Organization for Nuclear Research) · 2026
    10. Post-Exposure Syndromes as State-Space Trapping: A set-theoretic perspective on PSSD and the post-exposure family. Zenodo (CERN European Organization for Nuclear Research) · 2026
    11. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    12. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    13. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    14. Young patients using finasteride exhibit risk of suicidality The Brown University Psychopharmacology Update · 2021
    15. Sexuality in premature ovarian insufficiency Climacteric · 2019 · 32 citations
    16. Long COVID syndrome: An unfolding enigma The Indian Journal of Medical Research · 2024 · 17 citations
    17. Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link? PubMed · 2010 · 12 citations
    18. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia Translational Andrology and Urology · 2020 · 7 citations
    19. Acne 2019 · 4 citations
    20. Ottawa, Ontario, Canada, February 13–16, 2013 The Journal of Rheumatology · 2013 · 4 citations
    21. Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets Pharmaceutical Research · 2025 · 2 citations
    22. FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS RS Global journals (RS Global Sp. z O.O.) · 2026
    23. Finasteride-Induced Neuropsychiatric Reactions Journal of Dermatology and Skin Science · 2026
    24. Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 PLoS ONE · 2025
    25. Botanical Treatment for Polycystic Ovary Syndrome Elsevier eBooks · 2009
    26. Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review Revista Eletrônica Acervo Médico · 2022
    27. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020 International Journal of Molecular Sciences · 2020 · 848 citations
    28. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? Journal of the International Society of Sports Nutrition · 2021 · 140 citations
    29. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder Neuropsychopharmacology · 2015 · 110 citations
    30. Possible involvement of 5α-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells Brain Research · 2006 · 17 citations